• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

PRESSLED

Your Leading News Source

PRESSLED
Your Leading News Source

  • Home
  • BUSINESS
  • MONEY
  • POLITICS
  • REAL ESTATE
  • US
  • Meet the Reporters
  • About/Contact

Cambridge university spin-off HexagonFab secures £1.9M for next-gen biopharmaceuticals

May 14, 2021 by Staff Reporter

HexagonFab, a spin-off of the University of Cambridge, has secured a £1.9 million seed funding round. The funding round was led by Cambridge Enterprise, along with Parkwalk, NGVC, R42 Group, and several private investors.

How will the funding be used?

The proceeds from the seed funding will allow the company to grow its team, complete the development of its first product, the Bolt – an affordable and convenient handheld device that provides access to molecular binding analytics.

While the high cost and risk of failure limit the discovery and development of next-gen biopharmaceuticals, HexagonFab aims to change it by providing better analytical tools. 

Simplifies biomolecular interaction analysis

Through Bolt, the company will be focusing on simplifying the biomolecular interaction analysis of proteins and small molecules for pharma research and manufacturing. 

Powered by a graphene-based semiconductor sensor, the Bolt can detect proteins, antibodies, and small molecules down to a low nanomolar concentration, irrespective of their molecular weight or size. 

The Bolt can rapidly generate data on critical parameters during the R&D and production of biopharmaceuticals. It does not require installation.

With a real-time signal enabling the observation of binding events and measurement of binding affinity, the results are available in hours instead of days.

“Many researchers would like to get molecular binding data more conveniently and more frequently to guide them through a drug development project. HexagonFab aims to address this need with the Bolt. This investment will enable us to bring our game-changing product to the market. We look forward to the months ahead working closely with our lead customers,” said Christoph von Bieberstein, Founder and Commercial Director of HexagonFab.

“Our goal is to give researchers and production teams involved in the development of novel medicines faster and easier ways to understand the behaviour of the compounds. HexagonFab’s technology will accelerate the drug development process, leading to better and safer drugs in the future,” said Ruizhi Wang, Founder and Engineering Director of HexagonFab, who is leading the development of the Bolt.

“We are delighted to back HexagonFab and its new product, the Bolt. The technology will be used in the development of new biopharmaceuticals, which should ultimately lead to patient benefit.” said Christine Martin, Acting Head of Seed Funds, Cambridge Enterprise.

Originally Appeared On: https://www.uktech.news/news/cambridge-university-spin-off-hexagonfab-secures-19m-for-next-gen-biopharmaceuticals-20210420

Filed Under: Uncategorized

Primary Sidebar

More to See

EJ Jenkins Hopes to be a Versatile Receiving Threat for Georgia Tech This Season

One of Georgia Tech's most impactful incoming transfers could be EJ Jenkins. Jenkins is coming over from South Carolina, where he was used as a wide … [Read More...] about EJ Jenkins Hopes to be a Versatile Receiving Threat for Georgia Tech This Season

Stock futures dip following S&P 500’s third winning week in a row

Traders on the floor of the NYSE, Aug. 4, 2022.Source: NYSEStock futures traded slightly lower in overnight trading Sunday, following the S&P 500's … [Read More...] about Stock futures dip following S&P 500’s third winning week in a row

Why it is a must to choose your Realtor wisely?

In 2021, Las Vegas experienced its most frenzied market in years. Any agent could put a house on the market and it had a considerable chance to sell. … [Read More...] about Why it is a must to choose your Realtor wisely?

Privacy Policy | Terms and Conditions | About/ Contact
Copyright © 2022 · PRESSLED · As Amazon Associates we earn commissions from qualifying purchases · Log in

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT